Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF): 2017-2024

Historic Depreciation & Amortization (CF) for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $7.2 million.

  • Bicycle Therapeutics' Depreciation & Amortization (CF) fell 19.15% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 4.69%. This contributed to the annual value of $7.2 million for FY2024, which is 9.59% up from last year.
  • Bicycle Therapeutics' Depreciation & Amortization (CF) amounted to $7.2 million in FY2024, which was up 9.59% from $6.5 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Depreciation & Amortization (CF) peaked at $7.2 million during FY2024, and registered a low of $1.3 million during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Depreciation & Amortization (CF) value was $6.5 million (recorded in 2023), while the average stood at $5.8 million.
  • Data for Bicycle Therapeutics' Depreciation & Amortization (CF) shows a peak YoY soared of 161.82% (in 2022) over the last 5 years.
  • Bicycle Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $1.3 million in 2020, then grew by 10.34% to $1.4 million in 2021, then spiked by 161.82% to $3.7 million in 2022, then skyrocketed by 77.45% to $6.5 million in 2023, then increased by 9.59% to $7.2 million in 2024.